Brief: Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
25/07/2024 12:02
July 25 (Reuters) - Predictive Oncology Inc POAI.O :
* PREDICTIVE ONCOLOGY ENTERS BIOMARKER DISCOVERY MARKET
AFTER
SUCCESSFUL RETROSPECTIVE OVARIAN CANCER STUDY YIELDS COMPELLING
RESULTS
Source text for Eikon: ID:nGNX5st8fF
Further company coverage: POAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axe Compute
See all newsBrief: Axe Compute Announces $25.9 Million In Contracts Across Two Long-Term Agreements
Brief: Axe Compute - Discloses Updated Risk Factors On Gpu Infrastructure Expansion - SEC Filing
Axe Compute Q1 revenue falls as legacy sales decline, net loss widens
NASDAQ RESUMED AT 09:48 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM